SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-050581
Filing Date
2020-11-04
Accepted
2020-11-04 17:15:44
Documents
67
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 GTHX-Q3-2020 10-Q gthx-10q_20200930.htm   iXBRL 10-Q 1855479
2 EX-10.1 gthx-ex101_81.htm EX-10.1 74761
3 EX-10.2 gthx-ex102_82.htm EX-10.2 29184
4 EX-10.3 gthx-ex103_83.htm EX-10.3 40889
5 EX-31.1 gthx-ex311_8.htm EX-31.1 18793
6 EX-31.2 gthx-ex312_11.htm EX-31.2 18529
7 EX-32.1 gthx-ex321_9.htm EX-32.1 7309
8 EX-32.2 gthx-ex322_6.htm EX-32.2 7289
  Complete submission text file 0001564590-20-050581.txt   6452598

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA gthx-20200930.xsd EX-101.SCH 47319
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gthx-20200930_cal.xml EX-101.CAL 34598
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gthx-20200930_def.xml EX-101.DEF 123914
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE gthx-20200930_lab.xml EX-101.LAB 353801
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gthx-20200930_pre.xml EX-101.PRE 256917
14 EXTRACTED XBRL INSTANCE DOCUMENT gthx-10q_20200930_htm.xml XML 1070149
Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38096 | Film No.: 201287601
SIC: 2834 Pharmaceutical Preparations